Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lyden

Showing results (21-30 of 263) with videos related to

Pageof 27
Sort By:
Journal of the American College of Cardiology|March 1, 2008
Code stroke in the cath labPatrick D Lyden
International Review of Neurobiology|January 1, 1997
GABA and neuroprotectionP D Lyden
Annals of Neurology|February 3, 2018
When less is more (brain)-comment on "Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage"Patrick D Lyden
Neurology|November 14, 2024
Adverse Effects of Post-Recanalization Hemorrhagic Transformation: Asymptomatic but Not InconsequentialPatrick D Lyden
Stroke|May 5, 2012
In anticipation of International Stroke Trial-3 (IST-3)Patrick D Lyden
Stroke|August 6, 2011
Advanced brain imaging studies should not be performed in patients with suspected stroke presenting within 4.5 hours of symptom onsetPatrick D Lyden
Nature Reviews. Neurology|April 18, 2012
Stroke: Haemorrhage risk after thrombolysis--the SEDAN scorePatrick D Lyden
Nature Clinical Practice. Cardiovascular Medicine|March 29, 2006
Should all stroke patients receive tissue plasminogen activator therapy, despite mild or improving symptoms?Patrick D Lyden
Stroke|July 23, 2019
Thrombolytic Therapy for Acute Ischemic StrokePatrick D Lyden
Stroke|January 1, 1994
Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonistP D Lyden, L Lonzo
Pageof 27

Showing results (21-30 of 263) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|March 1, 2008
Code stroke in the cath labPatrick D Lyden
International Review of Neurobiology|January 1, 1997
GABA and neuroprotectionP D Lyden
Annals of Neurology|February 3, 2018
When less is more (brain)-comment on "Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage"Patrick D Lyden
Neurology|November 14, 2024
Adverse Effects of Post-Recanalization Hemorrhagic Transformation: Asymptomatic but Not InconsequentialPatrick D Lyden
Stroke|May 5, 2012
In anticipation of International Stroke Trial-3 (IST-3)Patrick D Lyden
Stroke|August 6, 2011
Advanced brain imaging studies should not be performed in patients with suspected stroke presenting within 4.5 hours of symptom onsetPatrick D Lyden
Nature Reviews. Neurology|April 18, 2012
Stroke: Haemorrhage risk after thrombolysis--the SEDAN scorePatrick D Lyden
Nature Clinical Practice. Cardiovascular Medicine|March 29, 2006
Should all stroke patients receive tissue plasminogen activator therapy, despite mild or improving symptoms?Patrick D Lyden
Stroke|July 23, 2019
Thrombolytic Therapy for Acute Ischemic StrokePatrick D Lyden
Stroke|January 1, 1994
Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonistP D Lyden, L Lonzo
Pageof 27